{"id": "10.1002_asia.200800173_fig_1", "figure_path": "images/9a8ab7f0b4daf85e87d6fdd6f89d88037b67550a262f6b96cb86664237b619af.jpg", "caption": "Figure 1. Acceptor alcohols and products in Table 4.", "referring_paragraphs": ["Having optimized the reaction conditions, the scope of the $\\mathrm{HClO_4}$ - catalyzed glycosidation was explored. Results of experiments for probing the scope of the alcohol component (Figure 1) with glucosyl phosphate 1 $(\\alpha /\\beta = 98:2)$ are summarized in Table 4."], "qa_pairs": [{"q": "图1中展示的是什么内容？", "a": "图1展示了表4中使用的受体醇及其对应的糖苷化产物。"}, {"q": "在表4中，哪个反应的产率最高？", "a": "在表4中，第2条目（使用受体醇6）的反应产率最高，为95%。"}, {"q": "哪些化合物是作为受体醇用于糖苷化反应的？", "a": "化合物5、6、7、8、9和10是作为受体醇用于糖苷化反应的。"}], "dialogue": [{"role": "user", "content": "图1中的化合物5-10代表什么？"}, {"role": "assistant", "content": "它们代表用于糖苷化反应的受体醇，这些醇与葡萄糖基磷酸酯1反应生成相应的糖苷产物11-16。"}, {"role": "user", "content": "为什么表4中需要列出α/β比例？"}, {"role": "assistant", "content": "因为糖苷化反应可能产生α或β异构体，α/β比例反映了反应的立体选择性，这对于评估反应条件和产物纯度非常重要。"}, {"role": "user", "content": "化合物14是如何形成的？"}, {"role": "assistant", "content": "化合物14是由葡萄糖基磷酸酯1与受体醇8在高氯酸催化下进行糖苷化反应生成的，产率为94%，α/β比例为89:11。"}], "short_caption": "图1：表4中使用的受体醇及产物结构式。", "long_caption": "图1展示了在高氯酸催化下，葡萄糖基磷酸酯1与多种受体醇（化合物5-10）进行糖苷化反应所生成的产物（化合物11-16）。这些受体醇包括不同取代基和骨架结构的分子，如含苄氧基的糖类衍生物、甾体醇、环己醇和对甲氧基苯酚等，体现了该糖苷化反应的广泛底物适用性。"}
{"id": "10.1002_asia.200800173_fig_2", "figure_path": "images/6e993126dae53749362168da9ed9104ae37baa6a8ed407b290ceba7f8ffdb83b.jpg", "caption": "Figure 2. Acceptor alcohols and products in Table 5. Fmoc = 9-fluorenylmethoxycarbonyl.", "referring_paragraphs": ["even with the less- reactive alcohol 5 (Table 5, entry 2). While galactosides were obtained in good to high yields in all cases, the selectivities were not as favorable as those obtained with 1 (Table 5, entries 1- 4). Selectivities appeared to depend on the reactivity of the acceptor alcohols: High  $\\alpha$  selectivities were observed in the reaction with less- reactive 4-  $o$  - unprotected glycosides 5 and 19, but the primary alcohol 3 leads to poor  $\\alpha$  selectivity  $(\\alpha /\\beta = 75:25)$", "The scope of the  $\\mathrm{HCIO_4}$  catalyzed glycosidation is not limited to the use of per-  $o$  - benzyl- protected donors. When 3,4,6- tri-  $o$  - acetyl- 2- azido- 2- deoxygalactosyl diphenyl phosphate (18,  $\\alpha /\\beta = 33:67$  was used as a donor, 0.2 equiv of  $\\mathrm{HCIO_4}$  an elevated temperature  $(25^\\circ\\mathrm{C})$  and longer reaction", "times were required to effect complete conversion owing to the attenuated reactivity of the donor.[37] Excellent stereocontrol was realized for serine and threonine derivatives 21 and 22, leading to predominant formation of  $\\alpha$ - glycosides  $27\\alpha$  and  $28\\alpha$ , which correspond to constituents of  $O$ - linked glycoproteins (Table 5, entries 5 and 6)."], "qa_pairs": [{"q": "图中化合物19和20的结构有何不同？", "a": "化合物19含有多个苄氧基（BnO）保护基，而化合物20含有甲氧基（OMe）和一个异丙叉保护基。"}, {"q": "化合物21和22的区别是什么？", "a": "化合物21中的R为H，而化合物22中的R为Me，即22是21的甲基化衍生物。"}, {"q": "为什么在使用化合物18作为供体时需要更长的反应时间和更高的温度？", "a": "因为化合物18的反应活性较低，所以需要0.2当量的高氯酸、升高温度至25°C并延长反应时间以实现完全转化。"}, {"q": "化合物27和28分别对应什么氨基酸衍生物？", "a": "化合物27对应丝氨酸衍生物（R=H），化合物28对应苏氨酸衍生物（R=Me）。"}, {"q": "图中哪些化合物与O-连接糖蛋白的组成相关？", "a": "化合物27α和28α与O-连接糖蛋白的组成相关，它们分别是丝氨酸和苏氨酸衍生物的α-糖苷。"}], "dialogue": [{"role": "user", "content": "图中化合物23、24和25的结构有什么共同点？"}, {"role": "assistant", "content": "这三种化合物都是多糖结构，由多个糖单元通过糖苷键连接而成，并且都含有苄氧基（BnO）保护基。"}, {"role": "user", "content": "为什么化合物26的结构与其他化合物不同？"}, {"role": "assistant", "content": "化合物26包含一个甲基取代的糖单元和一个异丙叉保护基，使其在结构上区别于其他主要含苄氧基或乙酰基保护基的化合物。"}, {"role": "user", "content": "图中Fmoc代表什么？"}, {"role": "assistant", "content": "Fmoc代表9-芴甲氧羰基，是一种常用于肽合成中的氨基保护基。"}], "short_caption": "图2展示了表5中使用的受体醇及其产物的化学结构。", "long_caption": "图2详细列出了在表5中用作受体醇及其相应产物的多种化合物的化学结构。其中包括含苄氧基和甲氧基保护基的单糖（如19和20）、氨基酸衍生物（如21和22）、多糖结构（如23、24和25）以及带有特殊取代基的糖苷（如26和27/28）。这些结构反映了不同保护基和官能团对糖苷化反应选择性和产率的影响。"}
{"id": "10.1002_asia.200800173_fig_3", "figure_path": "images/6d58d17b5d6d8791c39fc4823d9fffc81df26c6d5f411720e012c390f0278110.jpg", "caption": "Scheme 1. Synthesis of KRN7000.", "referring_paragraphs": ["In 1993, a research group of Kirin Brewery Co., Ltd. reported the isolation and characterization of agelasphins, the first glycosylceramides found as α-linked galactosides.[8] Owing to their significant antitumor activities in mice, these molecules hold promise as new lead structures for the development of antitumor therapeutics. Therefore, the Kirin group synthesized various analogues and concluded on the basis of their structure-activity relationships that (2S,3S,4R)-1-O-(α-D-galactopyranosyl)-2-(N-hexacosanolylamino)-1,3,4-octadecanetriol (29), named KRN7000, was the compound of choice for clinical trials.[39]", "With regard to the mechanism of action, KRN7000 was shown to act as a ligand for the CD1d receptor on antigen-presenting cells to form a complex which binds to natural killer (NK) T cells, leading to the stimulation of a cascade of cytokines.[40,41]", "Not surprisingly, the potent biological properties have aroused considerable interest in KRN7000 within the medicinal and synthetic chemistry communities, and routes to KRN7000 have been reported by 12 groups to date.[42] We then considered that a synthesis of KRN7000 would provide a stringent test for the glycosidation method presented herein, since glycosidations employing ceramides as acceptor alcohols frequently suffer from poor reactivity presumably owing to hydrogen-bond donation from the amide N-H group.[43]"], "qa_pairs": [{"q": "What is KRN7000 and why is it significant?", "a": "KRN7000 is (2S,3S,4R)-1-O-(α-D-galactopyranosyl)-2-(N-hexacosanolylamino)-1,3,4-octadecanetriol, a glycosylceramide with significant antitumor activities in mice, making it a promising candidate for clinical trials as an antitumor therapeutic."}, {"q": "What role does KRN7000 play in immunological mechanisms?", "a": "KRN7000 acts as a ligand for the CD1d receptor on antigen-presenting cells, forming a complex that binds to natural killer (NK) T cells, thereby stimulating a cascade of cytokines."}, {"q": "Why is synthesizing KRN7000 challenging?", "a": "Synthesizing KRN7000 is challenging because glycosidations using ceramides as acceptor alcohols often suffer from poor reactivity, likely due to hydrogen-bond donation from the amide N-H group."}], "dialogue": [{"role": "user", "content": "Can you explain the steps involved in synthesizing KRN7000 as shown in Scheme 1?"}, {"role": "assistant", "content": "The synthesis begins with donor 17 reacting with acceptor 30 under acidic conditions (HClO₄) in dioxane with molecular sieves at 25°C for 5 hours, yielding primarily the α-isomer 31α along with some β-isomer 31β. The ratio of α to β is influenced by the donor/acceptor ratio. Subsequently, catalytic hydrogenation using Pd(OH)₂/C removes protecting groups to yield the final product, KRN7000 (29)."}, {"role": "user", "content": "How does the reaction condition affect the stereochemical outcome?"}, {"role": "assistant", "content": "The reaction conditions, such as the molar ratio of donor 17 to acceptor 30, influence the α/β ratio of the product. For instance, a 1.0:1.1 ratio gives an 80% yield with a 90:10 α/β ratio, while a 1.1:1.0 ratio improves the yield to 92% with a 92:8 α/β ratio, indicating better stereocontrol with excess donor."}], "short_caption": "Synthetic route to KRN7000 (29) via glycosylation and deprotection steps.", "long_caption": "Scheme 1 illustrates the synthesis of KRN7000 (29), a biologically significant α-galactosylceramide. The process starts with the glycosylation of acceptor alcohol 30 with donor 17 under mild acidic conditions (HClO₄, dioxane, 5 Å molecular sieves, 25 °C, 5 h), yielding predominantly the α-anomer 31α along with minor amounts of the β-isomer 31β. The α/β selectivity can be tuned by adjusting the donor/acceptor ratio, achieving up to 92:8 α/β selectivity at 92% yield. Final deprotection via catalytic hydrogenation (H₂, 20% Pd(OH)₂/C, EtOH/CHCl₃, 12 h) removes benzyl groups to afford KRN7000 (29) in 73% yield. This synthesis highlights both the challenges and successes in constructing complex glycolipids with high stereocontrol."}
{"id": "10.1002_asia.200800173_fig_4", "figure_path": "images/78cbf790d1cd4bd4d4ee11f5f3de713f943b8f9c98517df8de60d680d37a9e59.jpg", "caption": "Scheme 2. Plausible mechanism of the $\\mathrm{HCIO_4}$ -catalyzed glycosidation with glycosyl diphenyl phosphates.", "referring_paragraphs": ["A control experiment established that the anomeric ratio of glycoside 4 $(\\alpha /\\beta = 2:98)$ did not change upon exposure to a stoichiometric amount of $\\mathrm{HClO_4}$ in the presence of $5 - \\mathrm{\\AA}$ M.S. in dioxane $\\mathrm{Et}_2\\mathrm{O}$ (1:1) even under reflux for $5\\mathrm{h}$, implying that the observed $\\alpha$ selectivity is the result of kinetic control.", "On the basis of this result, we propose the reaction pathway for $\\mathrm{HCIO_4}$ - catalyzed glycosidation using glycosyl diphenyl phosphates as glycosyl donors (Scheme 2).", "Diphenyl phosphate 32 is activated by protonation at the phosphoryl oxygen atom,[45] resulting in cleavage of the phosphate group to provide an equilibrium mixture of contact ion pair (CIP) 34 and glycosyl perchlorates[41] $35\\alpha$ and $35\\beta$, along with diphenyl phosphate."], "qa_pairs": [{"q": "What is the role of HClO₄ in the glycosidation reaction shown in Scheme 2?", "a": "HClO₄ acts as a catalyst by protonating the phosphoryl oxygen atom of glycosyl diphenyl phosphate 32, leading to cleavage of the phosphate group and formation of intermediates such as contact ion pair 34 and glycosyl perchlorates 35α and 35β."}, {"q": "Why is axial attack from the α face favored in the proposed mechanism?", "a": "Axial attack from the α face is favored due to the Kinetic Anomeric Effect (KAE), which leads to preferential formation of α-glycosides."}, {"q": "How does temperature influence the α selectivity in this reaction?", "a": "The α selectivity increases with increasing temperature because higher temperatures favor the equilibrium preference for the contact ion pair (CIP) 34, which promotes α-glycoside formation."}, {"q": "What is the significance of ethereal solvents in this reaction mechanism?", "a": "Ethereal solvents stabilize the contact ion pair (CIP) 34 and facilitate the formation of the solvent-separated ion pair (SSIP) 36, which are key intermediates in the glycosidation process."}, {"q": "Why might dioxane enhance α selectivity despite the unclear reason mentioned in the text?", "a": "Although the exact reason is unclear, it is speculated that the low anionicity of dioxane avoids solvent participation in forming oxonium ions, thus promoting glycosidation through CIP 34 and SSIP 36."}], "dialogue": [{"role": "user", "content": "Can you explain why the anomeric ratio doesn't change when glycoside 4 is exposed to HClO₄?"}, {"role": "assistant", "content": "The anomeric ratio remains unchanged because the observed α selectivity results from kinetic control rather than thermodynamic equilibration, meaning the reaction conditions do not allow for interconversion between α and β forms."}, {"role": "user", "content": "What happens after protonation of the phosphoryl oxygen in compound 32?"}, {"role": "assistant", "content": "After protonation, the phosphate group cleaves, producing an equilibrium mixture of contact ion pair (CIP) 34, glycosyl perchlorates 35α and 35β, and diphenyl phosphate."}, {"role": "user", "content": "Why is the stability of glycosyl perchlorates 35α and 35β important in this mechanism?"}, {"role": "assistant", "content": "Glycosyl perchlorates 35α and 35β are speculated to be unstable, so the equilibrium favors the more stable contact ion pair (CIP) 34, especially at higher temperatures, which drives the reaction toward α-glycoside formation."}], "short_caption": "Proposed mechanism for HClO₄-catalyzed glycosidation using glycosyl diphenyl phosphates.", "long_caption": "Scheme 2 illustrates the plausible mechanism of HClO₄-catalyzed glycosidation using glycosyl diphenyl phosphates as donors. The reaction begins with protonation of the phosphoryl oxygen in compound 32, leading to cleavage of the phosphate group and formation of intermediates including contact ion pair (CIP) 34 and glycosyl perchlorates 35α and 35β. Due to their instability, glycosyl perchlorates favor equilibration toward CIP 34, particularly at higher temperatures. Ethereal solvents stabilize CIP 34 and promote the formation of solvent-separated ion pair (SSIP) 36. Axial nucleophilic attack from the α face, driven by the Kinetic Anomeric Effect (KAE), leads to preferential formation of α-glycosides 37α while regenerating HClO₄. This mechanism explains the observed α selectivity and its enhancement at higher temperatures and in dioxane solvent."}
{"id": "10.1002_asia.200800173_table_1", "figure_path": "", "caption": "不同促进剂在糖基化反应中的效果比较", "referring_paragraphs": ["At the outset of this work, we speculated that an enhanced $\\alpha$ selectivity would be obtained by the use of less-reactive acceptor alcohols such as 4-O-unprotected glycosides owing to the kinetic anomeric effect (KAE).[35]", "Several promoters were screened in the reaction, and the results are compiled in Table 1.", "These results suggest that, for inexplicable reasons, the leaving group plays an important role in reaction selectivity."], "qa_pairs": [{"q": "表1中哪种促进剂对磷酸供体1的α选择性最高？", "a": "使用HClO4时，磷酸供体1的α/β比为84:16，表现出最高的α选择性。"}, {"q": "TMSOTf作为促进剂时，供体1和供体2的产率分别是多少？", "a": "TMSOTf作用下，供体1的产率为93%，供体2的产率为91%。"}, {"q": "为什么研究者更倾向于使用磷酸供体1而不是磷酰供体2？", "a": "因为磷酸供体1相较于磷酰供体2具有更高的α选择性和更好的反应性能。"}, {"q": "表1中哪些金属三氟甲磺酸盐被测试用于激活供体？", "a": "Cu(OTf)2和Sn(OTf)2被测试用于激活供体1和供体2。"}, {"q": "TMSClO4在何种溶剂中制备并使用？", "a": "TMSClO4是在甲苯中制备并使用的。"}], "dialogue": [{"role": "user", "content": "请解释一下表1中α/β比的意义。"}, {"role": "assistant", "content": "α/β比表示生成的二糖产物中α构型与β构型的比例，较高的α值意味着反应具有更好的α选择性。"}, {"role": "user", "content": "为什么HClO4和TMSClO4的效果优于其他促进剂？"}, {"role": "assistant", "content": "这可能与高氯酸根离子的有益效应有关，它能有效提高反应的α选择性和产率。"}, {"role": "user", "content": "表1中的时间t代表什么？"}, {"role": "assistant", "content": "时间t表示在特定促进剂作用下完成反应所需的时间，单位为分钟。"}], "short_caption": "促进剂对糖基化反应选择性的影响", "long_caption": "表1展示了多种促进剂（如TMSOTf、Cu(OTf)2等）在糖基化反应中的表现，包括反应时间、产率以及α/β选择性。结果表明，不同的促进剂对磷酸供体1和磷酰供体2的反应性能有显著影响。例如，HClO4和TMSClO4表现出优异的α选择性，而某些金属三氟甲磺酸盐则导致较低的选择性。这些数据为优化糖基化反应条件提供了重要参考。", "table_html": "<table><tr><td>Entry</td><td>Donor[a]</td><td>Promoter</td><td>t [min]</td><td>Yield [%]</td><td>α/β[b]</td></tr><tr><td>1</td><td>1</td><td>TMSOTf</td><td>5</td><td>93</td><td>79:21</td></tr><tr><td>2</td><td>2</td><td>TMSOTf</td><td>5</td><td>91</td><td>56:44</td></tr><tr><td>3</td><td>1</td><td>Cu(OTf)2</td><td>10</td><td>70</td><td>71:29</td></tr><tr><td>4</td><td>2</td><td>Cu(OTf)2</td><td>5</td><td>76</td><td>60:40</td></tr><tr><td>5</td><td>1</td><td>Sn(OTf)2</td><td>30</td><td>59</td><td>48:52</td></tr><tr><td>6</td><td>2</td><td>Sn(OTf)2</td><td>5</td><td>58</td><td>58:42</td></tr><tr><td>7</td><td>1</td><td>TMSCIO4[c]</td><td>5</td><td>95</td><td>83:17</td></tr><tr><td>8</td><td>2</td><td>TMSCIO4[c]</td><td>5</td><td>94</td><td>76:24</td></tr><tr><td>9</td><td>1</td><td>HClO4[d]</td><td>5</td><td>91</td><td>84:16</td></tr><tr><td>10</td><td>2</td><td>HClO4[d]</td><td>5</td><td>93</td><td>78:22</td></tr></table>"}
{"id": "10.1002_asia.200800173_table_2", "figure_path": "", "caption": "不同溶剂对糖苷化反应立体选择性的影响", "referring_paragraphs": ["To evaluate the beneficial effect of ethereal solvents, we next undertook a solvent survey in the $\\mathrm{TMSClO_4}$ - promoted glycosidation of phosphate 1 with alcohol 3 at $0^\\circ \\mathrm{C}$ (Table 2).", "In contrast, with the lone exception of THF Table 2, entry 4),good to high $\\alpha$ selectivities were obtained in ethereal solvents, with dioxane being the optimal solvent, although the high melting point of dioxane precluded a direct comparison (Table 2, entries 1, 5, and 6).[28]", "Since the use of $\\mathrm{Et}_2\\mathrm{O}$ as a cosolvent had no effect on reaction selectivity Table 2, entry 7), the mixed solvent system, which allowed the glycosidation to be run at lower temperatures, was chosen for further development."], "qa_pairs": [{"q": "哪种溶剂在表2中表现出最高的α选择性？", "a": "二氧六环（dioxane）表现出最高的α选择性，其α/β比为88:12。"}, {"q": "为什么选择混合溶剂系统进行进一步开发？", "a": "因为使用乙醚（Et₂O）作为共溶剂对反应选择性没有影响，而混合溶剂系统允许在较低温度下运行糖苷化反应。"}, {"q": "表2中哪个条目显示了最低的产率？", "a": "条目5（tBuOMe）显示了最低的产率为82%。"}, {"q": "THF作为溶剂时的α/β比是多少？", "a": "THF作为溶剂时的α/β比为62:38。"}, {"q": "二氧六环和乙醚混合溶剂的反应条件是什么？", "a": "二氧六环和乙醚混合溶剂的反应温度为0°C，产率为97%，α/β比为88:12。"}], "dialogue": [{"role": "user", "content": "表2中的最佳溶剂是什么？"}, {"role": "assistant", "content": "根据表2的数据，二氧六环（dioxane）是最佳溶剂，因为它提供了最高的α选择性（α/β = 88:12）。"}, {"role": "user", "content": "为什么二氧六环不能直接与其他溶剂比较？"}, {"role": "assistant", "content": "由于二氧六环的高熔点，无法直接与其他溶剂进行比较。"}, {"role": "user", "content": "混合溶剂系统的优点是什么？"}, {"role": "assistant", "content": "混合溶剂系统允许糖苷化反应在较低温度下进行，从而被选为进一步开发的条件。"}], "short_caption": "溶剂对糖苷化反应选择性的影响", "long_caption": "表2展示了不同溶剂对磷酸1与醇3在TMSClO₄促进下的糖苷化反应立体选择性的影响。结果表明，二氧六环是最优溶剂，具有最高的α选择性（α/β = 88:12），而CH₂Cl₂和甲苯导致显著的选择性下降。此外，混合溶剂系统因允许低温反应被选为后续优化条件。", "table_html": "<table><tr><td>Entry</td><td>Solvent</td><td>T [°C]</td><td>Yield [%]</td><td>α/β[a]</td></tr><tr><td>1</td><td>Et2O</td><td>0</td><td>85</td><td>83:17</td></tr><tr><td>2</td><td>CH2Cl2</td><td>0</td><td>89</td><td>62:38</td></tr><tr><td>3</td><td>toluene</td><td>0</td><td>87</td><td>66:34</td></tr><tr><td>4</td><td>THF</td><td>0</td><td>91</td><td>62:38</td></tr><tr><td>5</td><td>tBuOMe</td><td>0</td><td>82</td><td>82:18</td></tr><tr><td>6</td><td>dioxane</td><td>25</td><td>87</td><td>88:12</td></tr><tr><td>7</td><td>dioxane/Et2O 1:1</td><td>0</td><td>97</td><td>88:12</td></tr></table>"}
{"id": "10.1002_asia.200800173_table_3", "figure_path": "", "caption": "表3展示了温度、促进剂用量和供体异头物组成对立体选择性的影响。", "referring_paragraphs": ["An examination of the temperature profile of the reaction in dioxane $/\\mathrm{Et}_2\\mathrm{O}$ 1:1) demonstrated that a decrease in the reaction temperature to $- 20^{\\circ}\\mathrm{C}$ was accompanied by a decrease in $\\alpha$ selectivity Table 3, entries 1 vs 2 and 3).", "Since the $\\alpha$ selectivity and yield obtained at $0^\\circ \\mathrm{C}$ were comparable to those at $25^{\\circ}C$ Table 3, entries 2 vs 3), further optimization was performed at $0^\\circ \\mathrm{C}$."], "qa_pairs": [{"q": "在表3中，哪个实验条件下的产率最高？", "a": "在表3中，Entry 2的条件下（温度为0°C，使用TMSClO4作为促进剂），产率达到97%。"}, {"q": "表3中的数据如何说明温度对α选择性的影响？", "a": "从表3可以看出，当温度从-20°C升高到0°C时，α选择性从80:20提高到88:12；进一步升高到25°C时，选择性变化不大（89:11）。"}, {"q": "表3中不同促进剂对反应结果有何影响？", "a": "表3显示，使用HCIO4作为促进剂时，与TMSClO4相比，产物的α/β比值基本保持一致，但产率略有下降。"}, {"q": "表3中Entry 8与其他条目相比有何特殊之处？", "a": "Entry 8的特殊之处在于其操作步骤有所不同，先将供体1与HCIO4混合搅拌30分钟后，再加入醇3，导致产率降低至79%。"}, {"q": "表3中Donor 1的α/β比例如何影响最终产物的立体选择性？", "a": "表3显示，当Donor 1的α/β比例从98:2变为5:95时，产物的α/β比例仍保持较高水平，表明供体比例对选择性影响较小。"}], "dialogue": [{"role": "user", "content": "表3的主要目的是什么？"}, {"role": "assistant", "content": "表3的主要目的是研究温度、促进剂种类及用量以及供体异头物组成对反应立体选择性和产率的影响。"}, {"role": "user", "content": "为什么选择0°C作为进一步优化的温度？"}, {"role": "assistant", "content": "因为表3数据显示，在0°C下获得的α选择性和产率与25°C相当，且优于-20°C，因此选择0°C作为优化条件。"}, {"role": "user", "content": "表3中哪些条目使用了相同的温度条件？"}, {"role": "assistant", "content": "表3中Entry 2至Entry 8均在0°C条件下进行，而Entry 1是在-20°C条件下进行的。"}], "short_caption": "温度和促进剂对糖苷化反应选择性的影响", "long_caption": "表3详细列出了不同实验条件下糖苷化反应的结果，包括温度、促进剂种类及其用量对产率和立体选择性的影响。通过对比发现，较低温度会降低α选择性，而促进剂浓度的变化对选择性影响较小。此外，供体异头物组成的变化对最终产物的立体选择性影响有限。", "table_html": "<table><tr><td>Entry[a]</td><td>Donor 1 α/β</td><td>Promoter (equiv)</td><td>T [°C]</td><td>Yield [%]</td><td>α/β[b]</td></tr><tr><td>1</td><td>98:2</td><td>TMSClO4(1:5)</td><td>-20</td><td>92</td><td>80:20</td></tr><tr><td>2</td><td>98:2</td><td>TMSClO4(1:5)</td><td>0</td><td>97</td><td>88:12</td></tr><tr><td>3</td><td>98:2</td><td>TMSClO4(1:5)</td><td>25</td><td>92</td><td>89:11</td></tr><tr><td>4</td><td>98:2</td><td>TMSClO4(0:2)</td><td>0</td><td>93</td><td>90:10</td></tr><tr><td>5</td><td>98:2</td><td>TMSClO4(0:05)</td><td>0</td><td>94</td><td>91:9</td></tr><tr><td>6</td><td>98:2</td><td>HCIO4(0.05)</td><td>0</td><td>90</td><td>91:9</td></tr><tr><td>7</td><td>5:95</td><td>HCIO4(0.05)</td><td>0</td><td>92</td><td>88:12</td></tr><tr><td>8[c]</td><td>5:95</td><td>HCIO4(0.05)</td><td>0</td><td>79</td><td>90:10</td></tr></table>"}
{"id": "10.1002_asia.200800173_table_4", "figure_path": "", "caption": "高氯酸催化下全O-苄基保护的葡萄糖基二苯基磷酸酯1与受体醇的糖苷化反应结果。", "referring_paragraphs": ["Having optimized the reaction conditions, the scope of the $\\mathrm{HClO_4}$ - catalyzed glycosidation was explored. Results of experiments for probing the scope of the alcohol component (Figure 1) with glucosyl phosphate 1 $(\\alpha /\\beta = 98:2)$ are summarized in Table 4.", "It is noteworthy that alcohols 6 and 7 bearing acid-sensitive acetal or epoxy groups were safely glycosylated under these conditions with good $\\alpha$ selectivities (Table 4, entries 2 and 3).", "The advantage of employing a Bronsted acid $\\mathrm{(HClO_4)}$ as a promoter becomes evident for the stereoselective synthesis of aryl glycosides, as the present method delivered $p$ - methoxyphenyl (PMP) glucoside 16 free from contamination by rearranged products (Table 4, entry 6)."], "qa_pairs": [{"q": "表4中哪一种醇在最短时间内完成了糖苷化反应？", "a": "根据表4，编号为6的醇（ROH）在5分钟内完成了反应。"}, {"q": "使用高氯酸作为催化剂时，表4中的产物是否表现出较高的α选择性？", "a": "是的，所有产物均表现出较高的α选择性，范围从85:15到91:9。"}, {"q": "表4中胆固醇和金刚烷醇的糖苷化反应产率分别是多少？", "a": "胆固醇（ROH 8）和金刚烷醇（ROH 9）的糖苷化反应产率分别为94%和86%。"}, {"q": "表4中哪个条目显示了最低的反应时间？", "a": "表4中第2个条目（Entry 2）显示了最低的反应时间，仅为5分钟。"}, {"q": "表4中是否提到任何对酸敏感的基团也能成功进行糖苷化反应？", "a": "是的，带有酸敏感缩醛或环氧基团的醇（如6和7）也成功进行了糖苷化反应。"}], "dialogue": [{"role": "user", "content": "表4中哪些类型的醇被用于糖苷化反应？"}, {"role": "assistant", "content": "表4中包括多种类型的醇，例如含有酸敏感基团的醇、甾体醇（如胆固醇）以及叔醇（如金刚烷醇）。"}, {"role": "user", "content": "为什么使用高氯酸作为催化剂具有优势？"}, {"role": "assistant", "content": "高氯酸作为布朗斯特酸催化剂的优势在于可以避免路易斯酸催化过程中常见的O→C糖苷重排问题，从而实现芳基糖苷的立体选择性合成。"}, {"role": "user", "content": "表4中哪个产物的产率最高？"}, {"role": "assistant", "content": "表4中编号为6的醇生成的产物12具有最高的产率，达到95%。"}], "short_caption": "高氯酸催化糖苷化反应的实验结果。", "long_caption": "表4展示了高氯酸催化下全O-苄基保护的葡萄糖基二苯基磷酸酯1与不同受体醇的糖苷化反应结果。反应条件为二氧六环/乙醚（1:1）混合溶剂中加入5 Å分子筛，在0°C下进行。实验表明，该方法能够快速高效地获得多种1,2-顺式α-糖苷，且具有良好的α选择性。此外，酸敏感基团、甾体醇和叔醇均能安全参与反应。", "table_html": "<table><tr><td>Entry</td><td>ROH</td><td>t [min]</td><td>Glycoside</td><td>Yield [%]</td><td>α/β[a]</td></tr><tr><td>1</td><td>5</td><td>20</td><td>11</td><td>80</td><td>91:9</td></tr><tr><td>2</td><td>6</td><td>5</td><td>12</td><td>95</td><td>89:11</td></tr><tr><td>3</td><td>7</td><td>10</td><td>13</td><td>85</td><td>86:14</td></tr><tr><td>4</td><td>8</td><td>20</td><td>14</td><td>94</td><td>89:11</td></tr><tr><td>5</td><td>9</td><td>30</td><td>15</td><td>86</td><td>87:13</td></tr><tr><td>6</td><td>10</td><td>20</td><td>16</td><td>85</td><td>85:15</td></tr></table>"}
{"id": "10.1002_asia.200800173_table_5", "figure_path": "", "caption": "高氯酸催化的半乳糖基二苯基磷酸酯17和18的糖苷化反应数据表。", "referring_paragraphs": ["In an effort to expand the scope of the glycosidation method, we next examined the reaction of diphenyl phosphates 17 $(\\alpha /\\beta = 98:2)$ and 18 $(\\alpha /\\beta = 33:67)$ in the D- galacto series (Table 5, Figure 2).", "While galactosides were obtained in good to high yields in all cases, the selectivities were not as favorable as those obtained with 1 (Table 5, entries 1- 4)."], "qa_pairs": [{"q": "表格中哪种供体在0°C下反应时间最短？", "a": "供体17在0°C下的反应时间均为5分钟，是表格中反应时间最短的。"}, {"q": "表格中的糖苷化产物收率范围是多少？", "a": "根据表格数据，糖苷化产物的收率范围为77%到91%。"}, {"q": "表格中哪个条目显示了最高的α/β选择性？", "a": "条目6显示了最高的α/β选择性，比例为92:8。"}, {"q": "表格中哪些条目使用了供体18进行反应？", "a": "条目5和条目6使用了供体18进行反应。"}, {"q": "表格中涉及的温度条件有哪些？", "a": "表格中涉及的温度条件包括0°C和25°C。"}], "dialogue": [{"role": "user", "content": "这个表格主要展示了什么内容？"}, {"role": "assistant", "content": "该表格展示了高氯酸催化下，半乳糖基二苯基磷酸酯17和18与不同醇反应生成糖苷的数据，包括反应条件、产物收率及α/β选择性。"}, {"role": "user", "content": "为什么条目5和条目6的反应时间较长？"}, {"role": "assistant", "content": "因为条目5和条目6使用了供体18，其反应活性较低，因此需要更长的时间完成反应。"}, {"role": "user", "content": "表格中的α/β比例如何测定？"}, {"role": "assistant", "content": "表格注释中提到，α/β比例通过HPLC测定，使用Zorbax Sil色谱柱并采用特定流动相条件进行分析。"}], "short_caption": "半乳糖基供体17和18的糖苷化反应条件与结果。", "long_caption": "表格列出了高氯酸催化下，半乳糖基二苯基磷酸酯17和18与不同醇反应的详细数据，包括反应温度、时间、产物收率以及α/β选择性。实验结果显示，供体17的反应活性较高，可在较短时间内完成反应，而供体18则需要更长时间。此外，α/β选择性受接受体醇的反应活性影响显著。", "table_html": "<table><tr><td>Entry</td><td>Donor[a]</td><td>ROH</td><td>Equil HClO4</td><td>T [°C]</td><td>t [min]</td><td>Glycoside</td><td>Yield [%]</td><td>α/β[b]</td></tr><tr><td>1</td><td>17</td><td>3</td><td>0.05</td><td>0</td><td>5</td><td>23</td><td>88</td><td>75:25</td></tr><tr><td>2</td><td>17</td><td>5</td><td>0.05</td><td>0</td><td>5</td><td>24</td><td>77</td><td>90:10</td></tr><tr><td>3</td><td>17</td><td>19</td><td>0.05</td><td>0</td><td>5</td><td>25</td><td>82</td><td>87:13</td></tr><tr><td>4</td><td>17</td><td>20</td><td>0.05</td><td>0</td><td>5</td><td>26</td><td>91</td><td>87:13</td></tr><tr><td>5</td><td>18</td><td>21</td><td>0.2</td><td>25</td><td>120</td><td>27</td><td>82</td><td>91:9</td></tr><tr><td>6</td><td>18</td><td>22</td><td>0.2</td><td>25</td><td>360</td><td>28</td><td>78</td><td>92:8</td></tr></table>"}
